Tango Therapeutics Inc (TNGX)

SG&A Expense Growth

48.25%

Quarterly · Period ending:

TNGX logo

TNGX SG&A Expense Growth

Latest reported48.25%
TNGX Quarterly SG&A Growth (QoQ) (0.00% → 48.25%)
High-resolution chart · PNG

TNGX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tango Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
48.2507%
56.0483%
9.4016%
-21.3121%
-1.2108%
3.5167%
-1.1763%
4.1678%
1.0506%
17.0895%
5.9214%
12.1315%
16.9489%
1.8648%
-6.4544%
5.0871%
6.6645%
11.8054%
23.8213%
39.9306%
4.8659%
16.686%
2.8197%
5.8873%
21.7614%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.